• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-

Return to search Page to restart searchReturn to Orphan Designation Search PageReturn to Search Page
 
Generic Name:recombinant human monoclonal antibody against activin receptors type II
Trade Name:n/a
Date Designated: 06-18-2012
Orphan Designation:Treatment of inclusion body myositis
Orphan Designation Status: Designated
FDA Orphan Approval Status:Not FDA Approved for Orphan Indication
Novartis Pharmaceuticals Corp.
One Health Plaza
East Hanover, NJ 07936-1080

The sponsor address listed is the last reported by the sponsor to OOPD.

-
-